US Patent Issued to Quest Diagnostics Investments on April 22 for "Mass spectrometry assay for estrogenic compounds estradiol and estrone" (California Inventors)

ALEXANDRIA, Va., June 6 -- United States Patent no. 12,282,030, issued on April 22, was assigned to Quest Diagnostics Investments LLC (Secaucus, N.J.).

"Mass spectrometry assay for estrogenic compounds estradiol and estrone" was invented by Mildred Goldman (Laguna Niguel, Calif.) and Nigel J. Clarke (Vista, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods are provided for detecting the amount of one or more HRT panel analytes (i.e., estrone (E1), estrone sulfate (E1s), 17Alpha-estradiol (E2a), 17Beta-estradiol (E2b), estradiol sulfate (E2s), estriol (E3), equilin (EQ), 17Alpha-dihydroequilin (EQa), 17Beta-dihydroequilin (EQb), Equilenin (EN), 17Alpha-dihydroequilenin (ENa), 17Beta-dihydroequilen...